NUTRASORB LLC
Biotech · Private
Botanical extract from Moringa oleifera leaves containing stable isothiocyanates (MICs) for anti-inflammatory treatment
- Grants
- $762K
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201220132014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Agriculture · Targeting Childhood Obesity: Natural, Low Sugar Snacks With Concentrated Fruit Polyphenols | $99,882 | |
| Federal grant· 1 of 2 same day | Department of Agriculture · Targeting Childhood Obesity: Natural, Low Sugar Snacks With Concentrated Fruit Polyphenols | $1,131 | |
| Federal grant· 2 of 2 same day | Department of Agriculture · Targeting Childhood Obesity: Natural, Low Sugar Snacks With Concentrated Fruit Polyphenols | $449,740 | |
| Federal grant | Department of Health and Human Services · Phase I · Stable, antiinflammatory isothiocyanates from moringa may prevent and treat IBD | $123,667 | |
| Federal grant | Department of Health and Human Services · Phase I · Stable, antiinflammatory isothiocyanates from moringa may prevent and treat IBD | $71,129 | |
| Federal grant | Department of Health and Human Services · Phase I · Stable, antiinflammatory isothiocyanates from moringa may prevent and treat IBD | $17,300 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1114 | COMPANION SCIENCES, INC. | — | — |
| 1115 | Mu Therapeutics Inc. | — | — |
| 1116 | OPERATIONAL TECHNOLOGIES CORPORATION | — | — |
| 1117 | NUTRASORB LLC | — | — |
| 1118 | FGF Therapeutics INC. | — | — |
| 1119 | DURAVAX INC | — | — |
| 1120 | XGENOMES CORP. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.